| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
10,661 |
8,570 |
$1.19M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
7,815 |
5,897 |
$1.02M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,310 |
3,388 |
$764K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
9,502 |
7,825 |
$727K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,294 |
2,646 |
$313K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
7,335 |
1,834 |
$293K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,765 |
1,124 |
$282K |
| 70450 |
Computed tomography, head or brain; without contrast material |
4,076 |
2,393 |
$218K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,670 |
3,952 |
$199K |
| 71046 |
Radiologic examination, chest; 2 views |
4,736 |
3,386 |
$184K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,769 |
1,446 |
$165K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,462 |
1,068 |
$154K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
7,341 |
5,664 |
$152K |
| 71045 |
Radiologic examination, chest; single view |
6,199 |
3,405 |
$150K |
| G0378 |
Hospital observation service, per hour |
745 |
514 |
$146K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
8,080 |
3,976 |
$111K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
16,927 |
12,403 |
$97K |
| 83880 |
|
3,936 |
3,016 |
$80K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,456 |
1,262 |
$77K |
| 80053 |
Comprehensive metabolic panel |
10,966 |
8,353 |
$72K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,549 |
1,355 |
$67K |
| 87428 |
|
1,320 |
1,162 |
$61K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,290 |
1,879 |
$57K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,131 |
1,698 |
$57K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,454 |
3,896 |
$54K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
498 |
168 |
$52K |
| 36415 |
Collection of venous blood by venipuncture |
17,071 |
12,550 |
$46K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
7,132 |
5,551 |
$45K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
407 |
337 |
$40K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,494 |
1,208 |
$39K |
| 84484 |
|
5,976 |
3,812 |
$39K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
589 |
503 |
$35K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,186 |
787 |
$30K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
796 |
643 |
$30K |
| 81001 |
|
12,703 |
10,261 |
$29K |
| 87070 |
|
4,220 |
3,668 |
$29K |
| 80061 |
Lipid panel |
2,824 |
2,483 |
$28K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,612 |
1,360 |
$26K |
| 81025 |
|
3,865 |
3,267 |
$25K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,001 |
1,692 |
$22K |
| 97161 |
|
496 |
418 |
$21K |
| 87040 |
|
3,003 |
1,308 |
$20K |
| 82803 |
|
1,325 |
1,039 |
$20K |
| 72100 |
|
334 |
248 |
$19K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,567 |
2,241 |
$18K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
818 |
656 |
$15K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
140 |
77 |
$14K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,160 |
1,737 |
$11K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
264 |
240 |
$11K |
| 83690 |
|
2,659 |
1,998 |
$11K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
192 |
133 |
$10K |
| 82947 |
|
3,649 |
1,727 |
$9K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,745 |
1,448 |
$9K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
444 |
285 |
$9K |
| 36600 |
|
298 |
218 |
$8K |
| 87077 |
|
1,485 |
975 |
$8K |
| 83735 |
|
2,311 |
1,734 |
$8K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
28 |
25 |
$7K |
| 83605 |
|
1,420 |
1,015 |
$6K |
| 87186 |
|
928 |
669 |
$6K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
244 |
201 |
$6K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
225 |
188 |
$5K |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
1,638 |
1,050 |
$5K |
| 73562 |
|
102 |
76 |
$4K |
| 82248 |
|
1,079 |
936 |
$4K |
| 82150 |
|
813 |
681 |
$4K |
| 73030 |
|
104 |
74 |
$4K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
42 |
39 |
$3K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
2,472 |
1,977 |
$3K |
| 73610 |
|
54 |
41 |
$3K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
28 |
24 |
$3K |
| 73560 |
|
69 |
45 |
$2K |
| 87807 |
|
204 |
186 |
$2K |
| 51702 |
|
54 |
51 |
$2K |
| 85379 |
|
318 |
266 |
$2K |
| 74018 |
|
36 |
28 |
$2K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
14 |
13 |
$2K |
| 85610 |
|
544 |
414 |
$1K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
67 |
64 |
$1K |
| 73630 |
|
15 |
14 |
$884.78 |
| 87205 |
|
208 |
185 |
$826.60 |
| 86885 |
|
14 |
12 |
$825.38 |
| 87430 |
|
71 |
65 |
$796.12 |
| 82810 |
|
150 |
120 |
$726.23 |
| 82550 |
|
94 |
71 |
$701.73 |
| 86677 |
|
46 |
39 |
$641.19 |
| 85027 |
|
74 |
70 |
$639.04 |
| 86900 |
|
14 |
12 |
$619.50 |
| 82270 |
|
191 |
177 |
$611.38 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
26 |
25 |
$551.97 |
| 73130 |
|
19 |
12 |
$454.08 |
| 87420 |
|
30 |
29 |
$373.12 |
| 84550 |
|
85 |
69 |
$273.16 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
15 |
12 |
$243.25 |
| 82607 |
|
20 |
16 |
$201.79 |
| 84439 |
|
47 |
37 |
$188.92 |
| 86901 |
|
14 |
12 |
$187.27 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,684 |
1,304 |
$137.80 |
| 87210 |
|
45 |
41 |
$131.50 |
| 36000 |
|
440 |
382 |
$119.15 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
452 |
317 |
$40.69 |
| 85730 |
|
14 |
12 |
$16.83 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
694 |
380 |
$16.56 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
179 |
168 |
$12.67 |
| 99217 |
|
14 |
14 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
142 |
108 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
79 |
52 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
82 |
28 |
$0.00 |
| 90714 |
|
15 |
12 |
$0.00 |